Media Room

For More Information Contact

For Media Inquiries:

Dana Korsen

Mailing Address

The National Academies of Sciences, Engineering, and Medicine

Health and Medicine Division

500 Fifth St, NW
Washington, DC 20001

Selected Filters

    • Activity: Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials [Remove]
    • Date: More than 2 Years [Remove]
    • Type: Actions Taken [Remove]

Filter News

News and Announcements

The latest news from HMD, including information about new reports, activities, meetings, and other noteworthy events.

Actions Taken

National Cancer Institute Develops Checklist to Determine Readiness of an Omics Test

The National Cancer Institute (NCI) developed a checklist with 30 criteria for determining the readiness of an omics test for use in guiding patient care in clinical trials, based on the principles set forth in the IOM report Evolution of Translational Omics: Lessons Learned and the Path Forward. The checklist will be used when reviewing proposals for NCI-sponsored clinical trials in which omics tests will guide care.

Report at a Glance

Reports: Related Reports
Activities: Related Activities